GSK-3ß polymorphism rs6438552 alter transcription and splicing: relationship with depression disease

Fuente Vivas, Dalia de la

dc.contributor.advisor	Valdizán Ruiz, Elsa María
dc.contributor.author	Fuente Vivas, Dalia de la
dc.contributor.other	Universidad de Cantabria	es_ES
dc.date.accessioned	2015-11-16T08:54:36Z
dc.date.available	2020-07-21T02:45:12Z
dc.date.issued	2015-07-20
dc.identifier.uri	http://hdl.handle.net/10902/7660
dc.description.abstract	In this study, we reported the genetic consequences of the expression of SNP rs6438552 glycogen synthase-3ß (GSK-3ß) genotypes in transfected cells and its relationship with depression disease.	es_ES
dc.format.extent	32 p.	es_ES
dc.language.iso	eng	es_ES
dc.rights	Atribución-NoComercial-SinDerivadas 3.0 España	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/es/	*
dc.subject.other	Depression disease	es_ES
dc.subject.other	GSK-3β	es_ES
dc.subject.other	Single nucleotide polymorphism (SNP)	es_ES
dc.subject.other	Splicing	es_ES
dc.subject.other	β-catenin	es_ES
dc.subject.other	Polimorfismo de un solo nucleótido
dc.subject.other	Depresión
dc.title	GSK-3ß polymorphism rs6438552 alter transcription and splicing: relationship with depression disease	es_ES
dc.type	info:eu-repo/semantics/masterThesis	es_ES
dc.rights.accessRights	openAccess	es_ES
dc.description.degree	Máster en Iniciación a la Investigación en Salud Mental	es_ES